Clinical Services

NEOTIGASON (Acitretin)

NEOTIGASON (Acitretin)

NOTES

Neotigason (Acitretin) when taken systemically can cause birth defects in babies if they are exposed to them in the womb and it is therefore important to allow time for the drug to be cleared from the blood of a donor

DEFER:

  • For 36 months from last dose if donor is taking Acitretin (Neotigason)

IBTS/MEDD/DSGDE/0001Attachment 4.337Ver 1.1
Sign up to Our Newsletter

Sign up to Our Newsletter

loading form...